Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

tinawells pty ltd -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

tinawells pty ltd -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

tinawells pty ltd -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

markwell corporation pty ltd - heavy magnesium oxide, quantity: 600 mg/g (equivalent: magnesium, qty 361.86 mg/g); magnesium carbonate hydrate, quantity: 400 mg/g (equivalent: magnesium, qty 100.72 mg/g) - powder, oral - excipient ingredients: - maintain/support energy levels ; maintain/support energy production ; maintain/support body electrolyte balance ; maintain/support general health and wellbeing ; maintain/support healthy teeth ; maintain/support bone health ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; decrease/reduce/relieve constipation ; aperient/laxative ; maintain/support healthy immune system function ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support nerve conduction ; maintain/support nervous system health ; maintain/support nervous system function

Καναδάς - Αγγλικά - Health Canada

wellspring pharmaceutical canada corp - miconazole nitrate - cream - 2% - miconazole nitrate 2% - azoles

Καναδάς - Αγγλικά - Health Canada

wellspring pharmaceutical canada corp - miconazole nitrate - aerosol - 2% - miconazole nitrate 2% - azoles

Καναδάς - Αγγλικά - Health Canada

rockwell medical inc - iron (ferric pyrophosphate citrate) - solution - 1.5mg - iron (ferric pyrophosphate citrate) 1.5mg - iron preparations

Ινδία - Αγγλικά - Central Drugs Standard Control Organization

lglsi - 96 wells/kit

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - canakinumab 150mg - powder for injection - 150 mg - active: canakinumab 150mg excipient: histidine histidine hydrochloride polysorbate 80 sucrose - ilaris is indicated for the treatment of cryopyrin-associated periodic syndromes (caps), in adults and children aged 2 years and older including: · familial cold autoinflammatory syndrome (fcas) /familial cold urticaria (fcu) · muckle-wells syndrome (mws) · neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca).

Ισραήλ - Αγγλικά - Ministry of Health

megapharm ltd - anakinra - solution for injection - anakinra 150 mg/ml - anakinra - anakinra - kineret 100 mg solution for injection is indicated in adults for the treatment of the signs and symptoms of rheumatoid arthritis (ra) in combination with methotrexate, in patients with an inadequate response to methotrexate alone.kineret 100 mg solution for injection is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of cryopyrin-associated periodic syndromes (caps), including:- neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)- muckle-wells syndrome (mws)- familial cold autoinflammatory syndrome (fcas) kineret 100 mg solution for injection is indicated for the treatment of familial mediterranean fever (fmf). kineret 100 mg solution for injection should be given in combination with colchicine, if appropriate.